Alphatec Holdings, Inc. (NASDAQ:ATEC) was the target of a significant drop in short interest during the month of December. As of December 15th, there was short interest totalling 791,509 shares, a drop of 30.4% from the November 30th total of 1,137,916 shares. Based on an average daily volume of 149,012 shares, the short-interest ratio is presently 5.3 days. Currently, 8.2% of the company’s shares are sold short.

Several institutional investors have recently bought and sold shares of ATEC. Fondren Management LP raised its stake in shares of Alphatec by 20.8% during the second quarter. Fondren Management LP now owns 220,534 shares of the medical technology company’s stock valued at $408,000 after acquiring an additional 37,933 shares in the last quarter. Sabby Management LLC purchased a new position in Alphatec during the second quarter valued at approximately $629,000. Finally, Broadfin Capital LLC increased its holdings in Alphatec by 163.1% during the second quarter. Broadfin Capital LLC now owns 594,533 shares of the medical technology company’s stock valued at $1,100,000 after buying an additional 368,527 shares during the period. 15.70% of the stock is owned by hedge funds and other institutional investors.

Shares of Alphatec (NASDAQ:ATEC) opened at $2.66 on Monday. The company has a debt-to-equity ratio of -1.11, a quick ratio of 1.08 and a current ratio of 2.11. Alphatec has a 12 month low of $1.58 and a 12 month high of $5.80. The firm has a market cap of $44.49, a P/E ratio of -1.62 and a beta of 1.35.

Several brokerages have issued reports on ATEC. ValuEngine downgraded shares of Alphatec from a “sell” rating to a “strong sell” rating in a research note on Friday, December 1st. HC Wainwright reaffirmed a “buy” rating and set a $4.00 price target on shares of Alphatec in a research note on Wednesday, November 22nd. Finally, Lake Street Capital started coverage on shares of Alphatec in a research note on Monday, October 16th. They set a “buy” rating and a $7.00 price target for the company.

COPYRIGHT VIOLATION NOTICE: “Alphatec Holdings, Inc. (ATEC) Sees Significant Drop in Short Interest” was first reported by American Banking News and is the sole property of of American Banking News. If you are viewing this article on another publication, it was illegally stolen and reposted in violation of United States and international trademark & copyright laws. The legal version of this article can be read at

About Alphatec

Alphatec Holdings, Inc is a medical technology company. The Company through its subsidiary, Alphatec Spine, Inc and its subsidiaries, designs, develops, manufactures and markets products for the surgical treatment of spine disorders. Its product portfolio and pipeline addresses the cervical, thoracolumbar and intervertebral regions of the spine and covers a range of spinal disorders and surgical procedures.

Receive News & Ratings for Alphatec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alphatec and related companies with's FREE daily email newsletter.